Skip to main content Accessibility help
×
Home

Associations of plasma very-long-chain SFA and the metabolic syndrome in adults

  • Jing Zhao (a1), Xiaofan Li (a1), Xiang Li (a1), Qianqian Chu (a1), Yunhua Zhou (a2), Zi Li (a1), Hong Zhang (a3), Thomas J. Brenna (a4) (a5), Yiqing Song (a6) and Ying Gao (a1)...
  • Please note a correction has been issued for this article.

Abstract

Plasma levels of very-long-chain SFA (VLCSFA) are associated with the metabolic syndrome (MetS). However, the associations may vary by different biological activities of individual VLCSFA or population characteristics. We aimed to examine the associations of VLCSFA and MetS risk in Chinese adults. Totally, 2008 Chinese population aged 35–59 years were recruited and followed up from 2010 to 2012. Baseline MetS status and plasma fatty acids data were available for 1729 individuals without serious diseases. Among 899 initially metabolically healthy individuals, we identified 212 incident MetS during the follow-up. Logistic regression analysis was used to estimate OR and 95 % CI. Cross-sectionally, each VLCSFA was inversely associated with MetS risk; comparing with the lowest quartile, the multivariate-adjusted OR for the highest quartile were 0·18 (95 % CI 0·13, 0·25) for C20 : 0, 0·26 (95 % CI 0·18, 0·35) for C22 : 0, 0·19 (95 % CI 0·13, 0·26) for C24 : 0 and 0·16 (0·11, 0·22) for total VLCSFA (all Pfor trend<0·001). The associations remained significant after further adjusting for C16 : 0, C18 : 0, C18 : 3n-3, C22 : 6n-3, n-6 PUFA and MUFA, respectively. Based on follow-up data, C20 : 0 or C22 : 0 was also inversely associated with incident MetS risk. Among the five individual MetS components, higher levels of VLCSFA were most strongly inversely associated with elevated TAG (≥1·7 mmol/l). Plasma levels of VLCSFA were significantly and inversely associated with MetS risk and individual MetS components, especially TAG. Further studies are warranted to confirm the findings and explore underlying mechanisms.

Copyright

Corresponding author

*Corresponding author: Y. Gao, email yinggao@sibs.ac.cn

Footnotes

Hide All

The original version of this article was published with an incorrect author’s name. A notice detailing this has been published and the error rectified in the online PDF and HTML copies.

Footnotes

References

Hide All
1. Forouhi, NG, Koulman, A, Sharp, SJ, et al. (2014) Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the epic-interact case–cohort study. Lancet Diabetes Endocrinol 2, 810818.
2. Siri-Tarino, PW, Sun, Q, Hu, FB, et al. (2010) Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 91, 502509.
3. Wang, L, Manson, JE, Forman, JP, et al. (2010) Dietary fatty acids and the risk of hypertension in middle-aged and older women. Hypertension 56, 598604.
4. Calder, PC (2015) Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr 39, 18S32S.
5. Rocha, DM, Caldas, AP, Oliveira, LL, et al. (2016) Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis 244, 211215.
6. Mayneris-Perxachs, J, Guerendiain, M, Castellote, AI, et al. (2014) Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. Clin Nutr 33, 9097.
7. Kim, OY, Lim, HH, Lee, MJ, et al. (2013) Association of fatty acid composition in serum phospholipids with metabolic syndrome and arterial stiffness. Nutr Metab Cardiovasc Dis 23, 366374.
8. Lemaitre, RN, Fretts, AM, Sitlani, CM, et al. (2015) Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the cardiovascular health study. Am J Clin Nutr 101, 10471054.
9. Fernandez-Real, JM, Broch, M, Vendrell, J, et al. (2003) Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 26, 13621368.
10. Fretts, AM, Mozaffarian, D, Siscovick, DS, et al. (2014) Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the cardiovascular health study. J Am Heart Assoc 3, e000889.
11. Malik, VS, Chiuve, SE, Campos, H, et al. (2015) Circulating very-long chain saturated fatty acids and incident coronary heart disease in US men and women. Circulation 132, 260268.
12. Chung, HK, Cho, Y, Do, HJ, et al. (2015) Plasma phospholipid arachidonic acid and lignoceric acid are associated with the risk of cardioembolic stroke. Nutr Res 35, 10011008.
13. Fretts, AM, Mozaffarian, D, Siscovick, DS, et al. (2016) Associations of plasma phospholipid SFAs with total and cause-specific mortality in older adults differ according to SFA chain length. J Nutr 146, 298305.
14. Kihara, A (2012) Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem 152, 387395.
15. Yang, Y, Wang, G & Pan, X (2009) China Food Composition, 257303. Beijing: Peking University Medical Press.
16. Pewzner-Jung, Y, Brenner, O, Braun, S, et al. (2010) A critical role for ceramide synthase 2 in liver homeostasis: II. Insights into molecular changes leading to hepatopathy. J Biol Chem 285, 1091110923.
17. Samad, F, Badeanlou, L, Shah, C, et al. (2011) Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. Adv Exp Med Biol 721, 6786.
18. Mielke, MM, Bandaru, VV, Haughey, NJ, et al. (2012) Serum ceramides increase the risk of Alzheimer disease: the women’s health and aging study II. Neurology 79, 633641.
19. Choi, MJ & Maibach, HI (2005) Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol 6, 215223.
20. Grosch, S, Schiffmann, S & Geisslinger, G (2012) Chain length-specific properties of ceramides. Prog Lipid Res 51, 5062.
21. Grundy, SM, Cleeman, JI, Daniels, SR, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112, 27352752.
22. Sun, Q, Ma, J, Campos, H, et al. (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86, 7481.
23. Han, X, Rozen, S, Boyle, SH, et al. (2011) Metabolomics in early Alzheimer’s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS ONE 6, e21643.
24. Desquilbet, L & Mariotti, F (2010) Dose–response analyses using restricted cubic spline functions in public health research. Stat Med 29, 10371057.
25. Alhazmi, A, Stojanovski, E, Garg, ML, et al. (2014) Fasting whole blood fatty acid profile and risk of type 2 diabetes in adults: a nested case–control study. PLOS ONE 9, e97001.
26. Hata, J, Doi, Y, Ninomiya, T, et al. (2010) The effect of metabolic syndrome defined by various criteria on the development of ischemic stroke subtypes in a general Japanese population. Atherosclerosis 210, 249255.
27. Nystrom, PK, Carlsson, AC, Leander, K, et al. (2015) Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PLOS ONE 10, e0127111.
28. Janczura, M, Bochenek, G, Nowobilski, R, et al. (2015) The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function – an occupational cohort-based study. PLOS ONE 10, e0133750.
29. Chavez, JA & Summers, SA (2012) A ceramide-centric view of insulin resistance. Cell Metab 15, 585594.
30. Galadari, S, Rahman, A, Pallichankandy, S, et al. (2013) Role of ceramide in diabetes mellitus: evidence and mechanisms. Lipids Health Dis 12, 98.
31. Summers, SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45, 4272.
32. Wang, Y-X, Lee, C-H, Tiep, S, et al. (2003) Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113, 159170.
33. Li, TY, Brennan, AM, Wedick, NM, et al. (2009) Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr 139, 13331338.
34. Ohno, Y, Suto, S, Yamanaka, M, et al. (2010) Elovl1 production of c24 acyl-coas is linked to c24 sphingolipid synthesis. Proc Natl Acad Sci U S A 107, 1843918444.
35. Baik, I & Shin, C (2008) Prospective study of alcohol consumption and metabolic syndrome. Am J Clin Nutr 87, 14551463.
36. Brenna JT, Plourde M, Stark KD, et al. (2018) Best practices for the design, laboratory analysis, and reporting of trials involving fatty acids. Am J Clin Nutr (epublication ahead of print version 21 June 2018).
37. Chang, J & Wang, Y (2016) Chinese Residents of Nutrition and Health Condition Monitoring 2012–2013, pp. 108128. Beijing: Peking Medical University Press.

Keywords

Type Description Title
WORD
Supplementary materials

Zhao et al. supplementary material
Tables S1-S5

 Word (41 KB)
41 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

A correction has been issued for this article: